Even though eosinophils numbers were decreased, more detailed analysis of these eosinophils in primary care patients with COVID-19 revealed increased CD11b levels, whilst having decreased levels of CD62L, indicating baseline activation. This evidence concerns the gene ITGAM and COVID-19.